DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 146 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,337,323 | -7.5% | 1,098,604 | +2.3% | 0.00% | 0.0% |
| Q1 2024 | $13,332,883 | -2.2% | 1,074,366 | +10.2% | 0.00% | 0.0% |
| Q4 2023 | $13,628,809 | -11.0% | 974,879 | -6.0% | 0.00% | -25.0% |
| Q3 2023 | $15,318,957 | -3.5% | 1,037,167 | -15.6% | 0.00% | 0.0% |
| Q2 2023 | $15,876,057 | +19.8% | 1,228,797 | -9.0% | 0.00% | 0.0% |
| Q1 2023 | $13,251,818 | -4.8% | 1,350,848 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $13,921,833 | -2.7% | 1,308,443 | -4.6% | 0.00% | -20.0% |
| Q3 2022 | $14,312,000 | -11.8% | 1,370,938 | +6.4% | 0.01% | 0.0% |
| Q2 2022 | $16,218,000 | +163.8% | 1,288,156 | +127.2% | 0.01% | +150.0% |
| Q1 2022 | $6,147,000 | -21.7% | 567,023 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $7,854,000 | -33.0% | 558,213 | -8.5% | 0.00% | -33.3% |
| Q3 2021 | $11,724,000 | +2937.3% | 610,286 | +1455.4% | 0.00% | – |
| Q2 2021 | $386,000 | +48.5% | 39,236 | +48.6% | 0.00% | – |
| Q1 2021 | $260,000 | +170.8% | 26,398 | +22.5% | 0.00% | – |
| Q4 2020 | $96,000 | -89.5% | 21,551 | -86.6% | 0.00% | – |
| Q4 2019 | $917,000 | +1156.2% | 160,301 | +682.4% | 0.00% | – |
| Q3 2019 | $73,000 | -14.1% | 20,489 | -3.5% | 0.00% | – |
| Q2 2019 | $85,000 | -47.2% | 21,238 | -3.3% | 0.00% | – |
| Q1 2019 | $161,000 | -97.2% | 21,962 | -94.2% | 0.00% | -100.0% |
| Q2 2018 | $5,740,000 | -38.2% | 376,371 | -24.2% | 0.00% | -33.3% |
| Q4 2017 | $9,286,000 | +54.3% | 496,592 | +77.4% | 0.00% | +50.0% |
| Q3 2017 | $6,018,000 | +1094.0% | 279,905 | +435.8% | 0.00% | – |
| Q2 2017 | $504,000 | +65.2% | 52,239 | +1.8% | 0.00% | – |
| Q1 2017 | $305,000 | -80.3% | 51,340 | -36.2% | 0.00% | -100.0% |
| Q1 2016 | $1,549,000 | -60.1% | 80,527 | -49.8% | 0.00% | -50.0% |
| Q4 2015 | $3,879,000 | +4.8% | 160,536 | +6.4% | 0.00% | 0.0% |
| Q3 2015 | $3,701,000 | +61583.3% | 150,810 | +60224.0% | 0.00% | – |
| Q2 2015 | $6,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |